About Indian Immunologicals
Indian Immunologicals is a company based in Hyderabad (India) founded in 1982. Indian Immunologicals offers products and services including Animal Vaccines, Human Vaccines, and Hepatitis A Vaccine. Indian Immunologicals operates in a competitive market with competitors including Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
- Headquarter Hyderabad, India
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website indimmune.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Indian Immunologicals Limited
- Date of Incorporation 08 Oct, 1999
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1,513 Cr
FY 2025 · +8% YoY
- Net Profit₹473 Cr
FY 2025 · 31% margin
- EBITDA₹703 Cr
FY 2025 · 46% margin
Associated legal entities of Indian Immunologicals
Indian Immunologicals operates through Indian Immunologicals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Indian Immunologicals Limited CIN U72200TG1999PLC032666 | Active | 08 Oct 1999 | Hyderabad, Telangana | ₹1,513 Cr | 1,873 | 9 | View details |
Products & Services of Indian Immunologicals
Indian Immunologicals offers a comprehensive portfolio of products and services, including Animal Vaccines, Human Vaccines, and Hepatitis A Vaccine.
Vaccines designed to protect animals from diseases and promote health.
Vaccines for human preventive care against various illnesses.
First indigenously developed vaccine for hepatitis A prevention.
Apps and channels of Indian Immunologicals
its YouTube channel Indian Immunologicals Limited has 910 subscribers and 21 videos.
Videos from Indian Immunologicals
The most watched videos on Indian Immunologicals's YouTube channel, Indian Immunologicals Limited (910 subscribers). Click a video to play it here.
More on Indian Immunologicals Limited.
Board of directors of Indian Immunologicals Limited (Indian Immunologicals)
Indian Immunologicals Limited is the primary company behind Indian Immunologicals. The board of Indian Immunologicals Limited currently have 7 directors; the longest-serving is Anand Kumar Kanakasapapathy, appointed in 2013. 29 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anand Kumar Kanakasapapathy DIN 03268712 | Managing Director | 01 Nov 2013 | 12 yrs 11 mo | Indian Immunologicals Limited |
| Sanjay Madhav Mehendale DIN 08080775 | Director | 12 Mar 2018 | 8 yrs 6 mo | Indian Immunologicals Limited |
| Meeneshkumar Champaklal Shah DIN 03147155 | Director | 15 Jul 2021 | 5 yrs 2 mo | Indian Immunologicals Limited |
| Rajeev Sivarama DIN 09254521 | Director | 06 Aug 2021 | 5 yrs 2 mo | Indian Immunologicals Limited |
| Devanand Chakkingal Pathayapura DIN 07773929 | Director | 12 Nov 2021 | 4 yrs 10 mo | Indian Immunologicals Limited |
| Usha Ramachandra DIN 02831588 | Director | 18 Mar 2025 | 1 yr 6 mo | Indian Immunologicals Limited |
| Venkateswara Rao Thallapaka DIN 05273533 | Director | 18 Mar 2025 | 1 yr 6 mo | Indian Immunologicals Limited |
People of Indian Immunologicals
33 people are tracked at Indian Immunologicals (10 in leadership, 6 in board & advisors, 17 in team).
| Name | Role | Group |
|---|---|---|
K Anand Kumar | Managing Director | Leadership |
Ramit Rikhi | Chief Manager | Leadership |
G A Rajasekhar | CFO | Leadership |
Mc Muthiah | Vice President HR | Leadership |
Narendra Agrawal | Head-marketing HR & L&d | Leadership |
Sarthak Vasudeva | Vice President And Head - International Business | Leadership |
Shakul Srivastava | Vice President | Leadership |
Ajay Saini | Deputy General Manager | Leadership |
Sunil Tiwari | General Manager Quality | Leadership |
S Pradhan | Chief Manager - Planning (scm) | Leadership |
C P Devanand | Director | Board & advisors |
Shri S Rajeev | Director | Board & advisors |
A D M Chavali | Independent Director | Board & advisors |
B Kinnera Murthy | Independent Director | Board & advisors |
| Independent Director | Board & advisors | |
Meenesh C Shah | Chairman | Board & advisors |
Venkata Srinivas Adapa | Deputy Manager | Team |
Ananth Ram Pithani | Senior Executive | Team |
Lokesh Khandelwal | Regional Key Accounts | Team |
Arif Shaikh | QA | Team |
13 more people are available in the full profile.
Complete people profiles for Indian Immunologicals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Indian Immunologicals
Figures of Indian Immunologicals Limited, the primary company behind Indian Immunologicals, for FY 2025. Revenue was ₹1,513 Cr (+8% year on year). Net profit was ₹473 Cr (31% margin). EBITDA was ₹703 Cr (46% margin). Revenue has grown at a compounded annual rate of +22% over three years and +11% over five years.
- ₹1,513 CrRevenue · FY 2025 · +8% YoY
- ₹473 CrNet profit · 31% margin
- ₹703 CrEBITDA · 46% margin
- ₹54.00 CrPaid-up capital
- 1,873Employees (provident fund records)
- +22%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Indian Immunologicals Limited are on its company page.
Detailed financial statements for Indian Immunologicals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Indian Immunologicals
Indian Immunologicals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biologicale.com | 1953 | Hyderabad, India | – | 6,099 | Vaccines and therapeutics for multiple diseases are developed and marketed. | |
| vir.bio | 2017 | San Francisco, United States | $216M | 417 | Developer of therapeutics for the treatment of infectious diseases | |
| vaxcyte.com | 2013 | Foster, United States | $347M | 254 | Vaccines for infectious diseases are developed using cell-free protein synthesis. | |
| cidara.com | 2013 | San Diego, United States | $78.35M | 90 | Novel anti-infectives for bacterial and fungal infections are developed. | |
| freeline.life | 2015 | Stevenage, United Kingdom | $273.69M | 152 | Gene therapy platform is developed for chronic disease treatments. | |
| altimmune.com | 1997 | Gaithersburg, United States | $58M | 17 | Vaccines for infectious diseases and solid tumors are developed. | |
| valneva.com | 1999 | Lyon, France | $113.55M | – | Prophylactic vaccines for infectious diseases are developed and advanced. | |
| seruminstitute.com | 1966 | Pune, India | – | 6,617 | Vaccines and immuno-biological drugs for infectious diseases are manufactured. | |
| stridebio.com | 2015 | Durham, United States | $98.2M | 109 | AAV-based gene therapies for rare diseases are developed. | |
| redhillbio.com | 2009 | Ramat Gan, Israel | $13.5M | 183 | Developer of therapeutics for the treatment of gastrointestinal and infectious diseases |
Detailed competitors of Indian Immunologicals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Indian Immunologicals
The website of Indian Immunologicals (indimmune.com) receives about 16.1K visits a month and ranks #1,365,274 among all websites worldwide, #1,772 in Biotechnology and Pharmaceuticals.
- Monthly visits16.1K
▲ 13.1% vs previous month
- Unique visitors5K
per month
- Global rank#1,365,274
among all websites
- Category rank#1,772
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit4.1
- Average visit4 min 02 sec
- DevicesDesktop 46% · Mobile 54%
Websites whose visitors overlap most with Indian Immunologicals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bharatbiotech.com | 100% | 30.6K | #736,609 | View details | |
iilfast.com | iilfast.com | 96% | – | #8,279,682 | – |
| virchowbiotech.com | 96% | 1.4K | #4,149,585 | View details | |
| seruminstitute.com | 96% | 63.5K | #656,121 | View details | |
| vbivaccines.com | 96% | 11.4K | #3,481,567 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Indian Immunologicals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Indian Immunologicals
Complete news archive for Indian Immunologicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Indian Immunologicals
10 companies that operate in the same segment as Indian Immunologicals (Veterinary Digital Health), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Practice and prescription management software is provided for veterinary professionals. | 2010 | Portland, Oregon, United States | USD 291.64 M | – | – | |
Animal medicines, vaccines, and diagnostics are manufactured and supplied. | 2012 | Brussels, Brussels-capital Region, Belgium | – | – | – | |
Veterinary pharmacy services are delivered by VetSource to practices. | 2005 | Portland, Oregon, United States | USD 81.25 M | – | – | |
Animal health therapeutics are developed and supplied globally by Ceva. | 1999 | Libourne, Nouvelle-aquitaine, France | USD 214.35 M | – | – | |
Digital platform for pet insurance | 2020 | Stockholm, Sweden | USD 114.08 M | – | – | |
App based platform providing veterinary services and clinical management solutions for veterinarians | 2018 | Beverly Hills, California, United States | USD 58.81 M | – | – | |
Online client communication platform for veterinary doctors | 2013 | San Diego, California, United States | USD 14.11 M | USD 14.38 M | 1 | |
Virtual veterinary care is provided via an app platform. | 2018 | Los Angeles, California, United States | USD 210 M | – | 163 | |
Comprehensive customer engagement platform for veterinary clinics is provided. | 2015 | Austin, Texas, United States | USD 50.3 M | – | – | |
Veterinary appointments are booked via an online platform. | 2017 | Brooklyn, New York, United States | USD 243 M | – | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Indian Immunologicals
Indian Immunologicals was founded in 1982.
Indian Immunologicals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Indian Immunologicals, Indian Immunologicals Limited, reported revenue of ₹1,513 Cr for FY 2025, up 8% year on year.
The company was founded in 1982 in Hyderabad, India, and operates within the healthcare sector. Vaccines for both animal and human applications are developed and produced through dedicated research and development efforts. Novel products are created to address specific needs in health applications. Manufacturing processes are maintained to ensure consistent quality and delivery of these products.
Indian Immunologicals's top competitors include Vaxcyte, Serum Institute of India and Biological E.
Indian Immunologicals offers Animal Vaccines, Human Vaccines, and Hepatitis A Vaccine.
Indian Immunologicals operates through Indian Immunologicals Limited.
The legal entities of Indian Immunologicals currently have 9 directors, including Meeneshkumar Champaklal Shah, Appalaraja Sekhar Ganasala, Rajeev Sivarama and others.